FDA Inspection 1182334 — Lin, James P MD Inc. d.b.a. Reproductive Fertility Center
The FDA completed an inspection of Lin, James P MD Inc. d.b.a. Reproductive Fertility Center on October 19, 2022 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 19, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Irvine, CA (United States)